Executive Summary
This digest covers 50 filings from August 6, 2026, dominated by critical market events including insolvencies, tender offers, and M&A activity. A key theme is the surge in corporate insolvency actions in India, with Sun Granite Export Ltd and Value Industries Ltd entering or continuing CIRP, signaling distress in the Indian industrial sector.
The quantum computing SPAC merger between Bleichroeder Acquisition Corp. II and Pasqal reached a key milestone with SEC effectiveness, but carries significant governance and tax risks for shareholders. The healthcare sector saw a major acquisition with argenx's $77/share tender offer for Forte Biosciences, while Ensysce Biosciences executed a complex acquisition of Cy Biopharma with a $77 million financing package. Tender offer activity was mixed, with Apollo Debt Solutions BDC seeing strong demand (oversubscribed 3.36x), while several funds like Privacore PCAAM and AB Private Lending saw zero participation. Liberty Global's €1 billion acquisition of VodafoneZiggo closed, marking a major European telecom consolidation. Period-over-period data reveals a sharp 51% revenue decline at Morepen RX Limited and a 14.6% revenue drop at Jetking Infotrain Ltd, contrasting with 9.3% revenue growth at HCG Rajkot and strong advertising revenue growth at TIM Goa Airport Advertising (up 27% YoY).
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · DEFM14A · 425
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from August 05, 2026.
Investment Signals (12)
- Apollo Debt Solutions BDC ↓ (BULLISH)▲
Tender offer oversubscribed 3.36x (101.5M shares tendered vs 30.2M accepted), indicating strong shareholder demand and confidence in the BDC's portfolio quality
- Forte Biosciences ↓ (BULLISH)▲
Board unanimously recommends $77/share tender offer from argenx, representing a significant premium; supporting stockholders (directors/officers) owning ~1% of shares have already tendered, signaling insider alignment
- HCG Rajkot (Healthcare Global Enterprises) (BULLISH)▲
Revenue grew 9.3% YoY to INR 60.67 Cr, with parent company investing INR 16 Cr for expansion, showing strong operational momentum in cancer care
- TIM Goa Airport Advertising (GMR Airports) (BULLISH)▲
Advertising revenue grew 27% YoY (INR 23.70 Cr to INR 30.15 Cr) and 65% over two years, demonstrating high-growth airport monetization potential
- Ensysce Biosciences ↓ (BULLISH)▲
Secured up to $77M total financing from top-tier healthcare investors (Ally Bridge, Perceptive Advisors) for CY-200 CRPS therapy with FDA Orphan Drug Designation, providing strong validation and funding runway
- Olenox Industries (Safe & Green Holdings) (BULLISH)▲
Regained Nasdaq compliance after filing delinquent 10-K and 10-Q, removing delisting risk and restoring normal trading status
- Jetking Infotrain Ltd ↓ (BEARISH)▲
Net loss of Rs. 133.55 Lakh in Q1 FY27 vs profit of Rs. 39.56 Lakh in Q1 FY26, a swing of Rs. 173 Lakh, with revenue declining 14.6% YoY and expenses rising 10.5% YoY
- Morepen RX Limited (Morepen Laboratories) (BEARISH)▲
Revenue collapsed 51.7% YoY (₹11,276 Lakh to ₹5,449 Lakh) with net worth of only ₹47.72 Lakh, despite parent injecting ₹20 Cr via rights issue
- Sun Granite Export Ltd ↓ (BEARISH)▲
NCLT admitted CIRP petition with default of ₹3.96 Cr, loan classified as NPA in November 2025, and company disputes solvency but moratorium is now in effect
- Accuray Inc ↓ (BEARISH)▲
Transferred to Nasdaq Capital Market due to bid price non-compliance, a negative signal of financial distress and potential further downside risk
- Kajaria Bathware (Kajaria Ceramics) (BEARISH)▲
Net loss of ₹28.49 Cr on revenue of ₹413.64 Cr, with parent acquiring CCPS at a discount (₹50 Cr vs original ₹64.50 Cr investment), indicating ongoing operational challenges
- Liberty Global / VodafoneZiggo ↓ (BULLISH)▲
Completed €1B acquisition of Vodafone's 50% stake, with plans to spin off and list Ziggo Group on Euronext Amsterdam, creating a potential value unlock catalyst
Risk Flags (10)
- Sun Granite Export Ltd / Insolvency↓ [HIGH RISK]▼
NCLT admitted CIRP on August 5, 2026, with moratorium in effect. Loan classified as NPA on Nov 30, 2025. Company disputes default but faces potential liquidation.
- Value Industries Ltd / Insolvency↓ [HIGH RISK]▼
Remains under CIRP since September 2018 (8 years), delaying Q1 FY27 results. Resolution professional's registration expires Dec 31, 2026, creating timeline pressure.
- Jetking Infotrain Ltd / Financial Deterioration↓ [HIGH RISK]▼
Q1 FY27 net loss of Rs. 133.55 Lakh vs profit of Rs. 39.56 Lakh YoY. Revenue down 14.6% while expenses rose 10.5%, indicating severe cost structure issues. SAT dismissed appeal against BSE's rejection of preferential allotment.
- Accuray Inc / Delisting Risk↓ [HIGH RISK]▼
Transferred to Nasdaq Capital Market due to bid price <$1.00. Has 180 days (until Feb 1, 2027) to regain compliance, but failure could lead to delisting.
- Bleichroeder Acquisition Corp. II / SPAC Risks↓ [MEDIUM RISK]▼
Business combination with Pasqal faces shareholder approval risk, potential redemptions leaving insufficient cash, and New Pasqal will be a French foreign private issuer with reduced SEC oversight and IFRS reporting.
- Ensysce Biosciences / Nasdaq Delisting Risk↓ [MEDIUM RISK]▼
Company faces potential Nasdaq delisting and requires stockholder approval for Series C Preferred Stock conversion, creating uncertainty around the transaction structure.
- Morepen RX Limited / Subsidiary Distress [MEDIUM RISK]▼
Revenue declined 51.7% YoY with net worth of only ₹47.72 Lakh. Parent's ₹20 Cr rights issue may not be sufficient to turn around the subsidiary.
- ▼
Tender offer for $3.27M received zero shares tendered, indicating complete lack of investor interest in the fund's liquidity offer.
- AB Private Lending Fund / Zero Participation↓ [MEDIUM RISK]▼
Tender offer for up to 338,368 shares received zero tenders, signaling potential investor dissatisfaction with NAV or fund terms.
- Hydrofarm Holdings / Collection Risk↓ [MEDIUM RISK]▼
$5M of $16M sale proceeds in promissory note from Aurora Peat sale, with collectability risk. Logistics services business remains nascent and small.
Opportunities (10)
- Forte Biosciences / Tender Offer Arbitrage↓ (OPPORTUNITY)◆
$77/share cash tender offer from argenx, expiring August 26, 2026. With board recommendation and insider support, spread should narrow as expiration approaches.
- Liberty Global / VodafoneZiggo Spin-off↓ (OPPORTUNITY)◆
Completed €1B acquisition, plans to distribute Ziggo Group to shareholders and list on Euronext Amsterdam. Potential value unlock through spin-off and separate listing.
- Ensysce Biosciences / CY-200 Pipeline↓ (OPPORTUNITY)◆
Acquired Cy Biopharma's CRPS therapy with FDA Orphan Drug Designation. $77M financing from top-tier healthcare investors provides runway through Phase 2 proof-of-concept data.
- GMR Airports / TIM Goa Airport Advertising↓ (OPPORTUNITY)◆
Acquiring 49% of airport advertising business with 27% YoY revenue growth. Low entry valuation (~INR 16.59 Cr for 49%) with strong growth trajectory.
- ◆
SEC declared F-4 effective, proxy mailed. If approved, provides public market exposure to a leading French quantum computing company at a potentially attractive valuation.
- Apollo Debt Solutions BDC / Oversubscribed Tender↓ (OPPORTUNITY)◆
3.36x oversubscription indicates strong shareholder confidence. BDC structure may offer attractive yield with potential for capital appreciation.
- Olenox Industries / Nasdaq Compliance Restored (OPPORTUNITY)◆
Delisting risk removed after filing delinquent reports. Multiple acquisitions in 2025 suggest growth strategy, now with clean filing status.
- HCG Rajkot / Cancer Care Expansion (OPPORTUNITY)◆
9.3% revenue growth with INR 16 Cr investment for expansion. Cancer care is a high-growth sector in India with favorable demographics.
- Sun Granite Export Ltd / Distressed Asset Play↓ (OPPORTUNITY)◆
CIRP initiated with ₹3.96 Cr default. Resolution process may attract bids at a discount to asset value, though high risk.
- Kajaria Ceramics / CCPS Acquisition at Discount↓ (OPPORTUNITY)◆
Acquired CCPS of subsidiary at ₹50 Cr vs original ₹64.50 Cr investment, gaining full ownership at a 22.5% discount. Potential turnaround opportunity in bathware segment.
Sector Themes (6)
- Indian Corporate Insolvency Wave (HIGH IMPACT)◆
3 filings (Sun Granite Export, Value Industries, Majestic Research) involve CIRP or NCLT proceedings, indicating rising distress in Indian industrial and financial sectors. Sun Granite's CIRP admission on August 5, 2026, is the most recent and material.
- SPAC Merger Activity with Governance Concerns (MEDIUM IMPACT)◆
Bleichroeder/Pasqal merger highlights trend of SPACs targeting foreign private issuers, with reduced SEC oversight, IFRS reporting, and potential loss of Nasdaq governance protections. Shareholders face complex risk-reward tradeoffs.
- Healthcare M&A and Financing Surge (HIGH IMPACT)◆
argenx/Forte ($77/share) and Ensysce/Cy Biopharma ($77M financing) demonstrate robust healthcare M&A activity. Both involve premium valuations and top-tier investor participation, signaling sector confidence.
- Tender Offer Participation Divergence (MEDIUM IMPACT)◆
Apollo Debt Solutions BDC saw 3.36x oversubscription while Privacore PCAAM and AB Private Lending had zero participation. This bifurcation suggests investors are discriminating based on fund quality, NAV accuracy, and liquidity terms.
- Indian Subsidiary Distress and Parent Bailouts (MEDIUM IMPACT)◆
Morepen Laboratories (₹20 Cr rights issue) and Kajaria Ceramics (₹50 Cr CCPS acquisition) are injecting capital into struggling subsidiaries, highlighting the risk of parent companies being dragged down by underperforming units.
- European Telecom Consolidation (HIGH IMPACT)◆
Liberty Global's €1B acquisition of VodafoneZiggo and planned spin-off signals continued consolidation in European telecom, with potential for value creation through operational synergies and asset monetization.
Watch List (8)
-
$77/share tender offer expires August 26, 2026. Monitor acceptance rate and any competing bids. [August 26, 2026]
-
SEC declared F-4 effective, proxy mailed. Shareholder vote on Pasqal merger pending. Monitor redemption levels and approval. [Date TBD]
-
CIRP initiated August 5, 2026. Monitor IRP actions, creditor meetings, and potential resolution plans. [Ongoing]
-
180-day compliance period until February 1, 2027. Monitor stock price and any reverse split announcements. [February 1, 2027]
-
Plans to distribute Ziggo Group to shareholders and list on Euronext Amsterdam. Monitor spin-off timeline and valuation. [Date TBD]
-
Requires approval for Series C Preferred Stock conversion. Monitor vote outcome and milestone achievement for second financing tranche. [Date TBD]
-
Singapore subsidiary incorporation and new auditor appointment. Monitor Q2 FY27 results for signs of operational improvement. [November 2026]
-
Resolution professional's registration expires December 31, 2026. Monitor for resolution plan approval or liquidation order. [December 31, 2026]
Filing Analyses
(50)
06-08-2026
Health Catalyst, Inc. filed an 8-K on August 6, 2026, reporting the termination of a material definitive agreement (Item 1.02) and the completion of an acquisition or disposition of assets (Item 2.01). The filing also includes results of operations and financial condition (Item 2.02) and Regulation FD disclosure (Item 7.01). However, the filing does not disclose the counterparty, deal value, or specific financial metrics, limiting the ability to assess the transaction's materiality or strategic impact.
- · Filing includes Item 1.02 (Termination of Material Definitive Agreement) and Item 2.01 (Completion of Acquisition or Disposition of Assets), but no specific counterparty, deal value, or asset details are disclosed.
- · Item 2.02 (Results of Operations and Financial Condition) is referenced but no financial metrics (revenue, EPS, etc.) are provided in the filing summary.
- · Item 7.01 (Regulation FD Disclosure) is included, suggesting a concurrent public disclosure, but content is not specified.
- · No scheduled events (e.g., earnings calls, shareholder meetings) are mentioned in the filing.
06-08-2026
RB International Holdings Limited (Acquirer-1), Suyog Yogesh Desai (Acquirer-2), and Nikita Suyog Desai (Acquirer-3) have announced an open offer to acquire up to 23,42,295 equity shares (26% of equity share capital) of RR Metalmakers India Limited from public shareholders, at a face value of ₹10 per share. The offer follows a Share Purchase Agreement with promoters Virat Sevantilal Shah and Alok Virat Shah, who will cease to be promoters post-transaction. The acquirers currently hold no shares in the target company and intend to retain its listing status, with no minimum acceptance condition or delisting proposal.
- · The open offer is not conditional upon any minimum level of acceptance (Regulation 19(1) of SEBI SAST).
- · The acquirers have not been prohibited by SEBI from dealing in securities and are not categorized as wilful defaulters or fugitive economic offenders.
- · No competitive offer exists in terms of Regulation 20 of SEBI SAST.
- · The acquirers have no plans to dispose of or encumber material assets of the target company in the next 2 years, except in ordinary course or with shareholder approval.
- · The target company must maintain at least 25% public shareholding post-offer as per SEBI LODR and SCRR rules.
06-08-2026
Ensysce Biosciences acquired Cy Biopharma in a stock-for-stock merger, gaining a clinical-stage neuroplastogenic therapy (CY-200) for Complex Regional Pain Syndrome (CRPS) with FDA Orphan Drug Designation. Concurrently, the company secured up to $77 million in total financing: $21.5 million from an initial private placement (led by Ally Bridge Group, with Perceptive Advisors, Dellora Investments, Ikarian Capital, and Adage Capital Partners), $17.1 million in cash from Cy Biopharma's pre-acquisition convertible note, and up to $38.6 million upon a clinical milestone. Pro forma cash is expected to fund CY-200 through Phase 2 proof-of-concept data and into registrational development, while Ensysce continues its PF614-MPAR program. However, the transaction requires stockholder approval for the Series C Preferred Stock conversion, and the company faces risks including potential Nasdaq delisting and failure to achieve the milestone for the second tranche.
- · The acquisition is structured as a stock-for-stock merger with a fixed exchange ratio for 282,122 shares of Series C Preferred Stock (282,122,000 on as-converted basis).
- · Series C Preferred Stock conversion ratio is 1:1,000 to common stock, subject to stockholder approval and beneficial ownership limitations.
- · The private placement price is $321.79 per share ($0.32179 per share on as-converted basis) for the initial tranche and $402.24 per share ($0.40224 per share on as-converted basis) for the milestone tranche.
- · The company resolved existing contractual matters with a third party by converting outstanding Series B Preferred Stock and warrants into common and Series C Preferred Stock.
- · The initial close of the private placement is expected on August 7, 2026.
- · The milestone closing is contingent on achievement of a clinical trial milestone.
- · Risks include possible Nasdaq delisting, failure to obtain stockholder approval for conversion, and failure to achieve the clinical milestone for the second tranche.
- · The combined fully diluted equity value is approximately $101.4 million (excluding transaction fees).
06-08-2026
06-08-2026
Ekam Leasing and Finance Co. Ltd. has filed a Second Motion Application with the NCLT, New Delhi Bench, on August 5, 2026, as part of the Scheme of Amalgamation involving Rex Overseas Private Limited and S & S Balajee Mercantile Private Limited as transferor companies. This filing follows the First Motion Order dated May 12, 2026, and the equity shareholders' meeting held on July 24, 2026. No financial details or updates on the scheme's timeline or shareholder approval metrics are disclosed.
- · Second Motion Application filed on August 5, 2026, with NCLT New Delhi Bench under Company Application No. (CAA) 17 (ND) 2026.
- · Continues from First Motion Order dated May 12, 2026, and July 24, 2026 shareholder meeting outcome.
06-08-2026
Bleichroeder Acquisition Corp. II (BBCQU) filed a definitive proxy statement (DEFM14A) for its proposed business combination with Pasqal, a French quantum computing company, which includes a reincorporation merger to form New Pasqal. The filing highlights significant risks for shareholders, including reduced regulatory oversight as a foreign private issuer, potential loss of that status, and adverse tax consequences if the merger fails to qualify as a tax-free reorganization. While the transaction offers a path to public listing for Pasqal, shareholders face uncertainties regarding governance protections, legal enforcement, and tax treatment.
- · New Pasqal will be incorporated under French law and will prepare financial statements in accordance with IFRS, not U.S. GAAP.
- · As a foreign private issuer, New Pasqal will file annual reports on Form 20-F and furnish reports on Form 6-K, which are less extensive and timely than U.S. domestic issuer filings.
- · New Pasqal may rely on foreign private issuer exemptions from certain Nasdaq corporate governance requirements, potentially resulting in a board without a majority of independent directors.
- · The Reincorporation Merger is intended to qualify as a tax-free reorganization under Section 368(a)(1)(F) of the Code, but no IRS ruling will be sought.
- · New Pasqal may be classified as a PFIC, which could lead to adverse U.S. federal income tax consequences for U.S. holders.
- · Shareholders may face difficulties enforcing U.S. judgments against New Pasqal or its directors and officers, as most assets are located outside the U.S.
06-08-2026
ARGENX SE, through its subsidiary Avena Merger Sub Inc., has launched a tender offer to acquire all outstanding shares of Forte Biosciences, Inc. for $77.00 per share in cash. The offer is part of a merger agreement dated July 26, 2026, and is supported by certain Forte stockholders via a Tender and Support Agreement. The transaction represents a strategic acquisition by argenx to expand its pipeline.
- · The tender offer is scheduled to expire on a date to be specified in the Offer to Purchase, subject to extension.
- · The offer is conditioned on customary terms, including the tender of a majority of the outstanding shares.
- · A Tender and Support Agreement was signed with certain Forte stockholders on July 26, 2026.
- · The transaction is structured as a third-party tender offer under Rule 14d-1.
- · A joint press release and investor presentation were issued on July 27, 2026.
06-08-2026
Value Industries Limited, along with 12 other Videocon group companies, remains under Corporate Insolvency Resolution Process (CIRP) initiated by NCLT orders from September 2018 and subsequent dates. The company will delay submission of its quarterly financial results for the quarter ended June 30, 2026, due to procedural constraints under CIRP, and plans to file them together with audited annual results for FY2026-27 once processes are completed.
- · CIRP was initiated by NCLT order dated 05th September 2018, with subsequent orders on 8th August 2019 and 25th September 2019.
- · The company cites practical and procedural constraints in finalizing financial results under CIRP as the reason for delay.
- · The resolution professional's registration is valid until December 31, 2026.
06-08-2026
Mr. Karronn Naresh Bajaj has launched a mandatory open offer to acquire up to 22,88,000 equity shares (26% of voting capital) of Mitshi India Limited at ₹15 per share, for a total consideration of ₹3,43,20,000. The offer opens on September 16, 2026 and closes on September 29, 2026, and is not conditional on any minimum acceptance level. The filing does not provide any financial performance data for the target company, so no period-over-period comparisons are available.
- · The offer is made under Regulation 4 of SEBI (SAST) Regulations, 2011.
- · The Identified Date for determining shareholders to whom the Letter of Offer will be sent is September 1, 2026.
- · The last date for upward revision of Offer Price and/or Offer Size is September 15, 2026.
- · No competing offer exists as of the date of the Draft Letter of Offer.
- · The offer is not conditional upon any minimum level of acceptance.
- · If the number of shares tendered exceeds the offer size, acceptance will be on a proportionate basis.
- · The Acquirer may withdraw the offer only under specific circumstances outlined in Regulation 23 of SEBI (SAST) Regulations.
06-08-2026
Forte Biosciences, Inc. (FBRX) has filed a Schedule 14D-9 recommending that stockholders tender their shares in response to a tender offer by Avena Merger Sub Inc., a subsidiary of argenx BV, at $77.00 per share in cash. The offer, which commenced on August 6, 2026, is part of a merger agreement dated July 26, 2026, and is expected to close following the offer expiration on August 26, 2026. The Company's board recommends acceptance, noting the premium to market, but stockholders should consider the risks and conditions outlined in the filing.
- · The tender offer expires at one minute after 11:59 p.m. Eastern Time on August 26, 2026, unless extended.
- · The merger will be effected under Section 251(h) of the Delaware General Corporation Law without a stockholder vote.
- · Supporting Stockholders (directors and executive officers) owned approximately 1% of outstanding Shares as of July 26, 2026.
- · The Company's board recommends that stockholders tender their shares in the offer.
- · The offer price of $77.00 per share represents a premium to the market price prior to announcement.
06-08-2026
Morepen Laboratories Limited has subscribed to a rights issue of its wholly owned subsidiary, Morepen RX Limited (MRX), by acquiring 2,00,00,000 equity shares at ₹10 each for a total consideration of ₹20,00,00,000 (₹20 Crore). The investment aims to strengthen MRX's capital base and support its business operations. However, MRX's turnover declined sharply from ₹11,276.35 Lakh in FY2024-25 to ₹5,449.84 Lakh in FY2025-26, a drop of over 51%, while its net worth stood at only ₹47.72 Lakh as of March 2026.
- · MRX was incorporated on 17 March 2023 and is engaged in sales and marketing of branded prescription products in India.
- · The rights issue shares were allotted at par value of ₹10 each.
- · The Finance Committee of Morepen Laboratories' Board took note of the allotment.
- · The transaction is a related party transaction as promoter group members Sanjay Suri, Varun Suri, and Shalu Suri are directors of MRX.
06-08-2026
OBCL Infrastructure Private Limited, a member of the promoter group of OBCL Limited (formerly Orissa Bengal Carrier Ltd.), acquired a total of 67,081 equity shares of the company through on-market transactions on August 3, 4, and 5, 2026. The acquisitions were made at an average price of approximately ₹12,412 per share, increasing the promoter group's holding from 20,00,000 shares (9.015%) to 20,00,232 shares (9.015% — effectively flat). The filing is a routine disclosure under SEBI's insider trading regulations and does not represent a material change in control or strategy.
- · The promoter group entity's pre-acquisition holding was 20,00,000 shares (9.015% of total paid-up equity).
- · Post-acquisition holding is 20,00,232 shares, representing a negligible increase of 0.001% in percentage terms.
- · The trades were executed on BSE and NSE on three consecutive days.
- · No derivatives trading was reported by the acquirer.
06-08-2026
An open offer has been announced by Annjana Dugar, Likhitta Dugar, and Antariksh Dugar (Acquirers), together with Padam Dugar (PAC), to acquire up to 6,54,966 equity shares of Colinz Laboratories Limited at ₹54 per share, aggregating to ₹3,53,68,164. The offer represents 26% of the voting share capital and is made to public shareholders under SEBI (SAST) Regulations. The offer opening public announcement was published on August 6, 2026, in Financial Express, Jansatta, and Pratahkal newspapers.
- · The offer is managed by Saffron Capital Advisors Private Limited (SEBI Registration No: INM000011211).
- · The offer opening public announcement was published on August 6, 2026, in Financial Express (English, all editions), Jansatta (Hindi, all editions), and Pratahkal (Marathi, Mumbai edition).
- · The target company's shares are listed on BSE Limited (Scrip Code: 531210).
- · Contact persons for clarifications: Saurabh Gaikwad (saurabh@saffronadvisor.com, +91 22 49730394) and Shivam Sharma (shivam@saffronadvisor.com).
06-08-2026
Olenox Industries Inc. (NASDAQ: OLOX) announced it has regained compliance with Nasdaq's periodic filing requirement (Listing Rule 5250(c)(1)) after filing its delinquent Form 10-K for FY2025 and Form 10-Q for Q1 2026. The company received a confirmation letter from Nasdaq on August 4, 2026, and its common stock will continue trading on The Nasdaq Capital Market. CEO Mike McLaren attributed the prior delinquency to a busy year of multiple acquisitions and a change of independent auditors.
- · The company had been delinquent in filing its Form 10-K for the period ended December 31, 2025, and Form 10-Q for the period ended March 31, 2026.
- · Nasdaq granted an extension until July 31, 2026, to file the delinquent reports; the company filed the Form 10-K on June 30, 2026, and the Form 10-Q on July 31, 2026.
- · The company changed its name from Safe & Green Holdings Corp. to Olenox Industries Inc. on December 19, 2022.
- · Olenox describes itself as a vertically integrated U.S. energy company operating across oil and gas, energy services, and energy technologies.
06-08-2026
Vystar Corporation entered into a joint venture with Capital Realm, Inc. to acquire a 50% interest each in r3alm, Inc., a compliance-focused AI and Web3 financial ecosystem. Vystar issued 8,371 shares of Series B preferred stock (convertible into 8,371,000 common shares, representing 34% ownership) to Capital Realm, with the shares fully vesting upon proof of intellectual property concept. The transaction was exempt under Regulation D.
- · Joint venture formed on August 4, 2026, with agreements dated July 28, 2026.
- · Vystar issued 8,371 Series B preferred shares convertible into 8,371,000 common shares (34% ownership) to Capital Realm.
- · Shares fully vest upon proof of intellectual property concept.
- · Transaction exempt under Regulation D of the Securities Act of 1933.
- · R3alm platform includes 22 planned modules spanning digital capital formation, tokenized assets, governance, trading, treasury, identity, analytics, and AI-powered financial intelligence.
- · Platform aims to help small and micro-cap companies tokenize stocks for 24-hour domestic and international trading.
06-08-2026
Bleichroeder Acquisition Corp. II and Pasqal Holding SAS announced on August 6, 2026 that the SEC declared effective their registration statement on Form F-4 for the proposed business combination. The definitive proxy statement/prospectus has been mailed to Bleichroeder shareholders as of August 4, 2026, with the transaction still subject to shareholder and regulatory approvals.
- · SEC declared effective the registration statement on Form F-4 (File No. 333-296239) on August 5, 2026.
- · Registration statement was originally filed on May 26, 2026.
- · Definitive proxy statement/prospectus mailed to Bleichroeder shareholders as of August 4, 2026 record date.
- · Business Combination Agreement has been amended three times (Amendment No. 1 on May 26, 2026; Amendment No. 2 on June 25, 2026; Amendment No. 3 on July 22, 2026).
- · Bleichroeder's securities trade on Nasdaq under symbols BBCQU (Units), BBCQ (Class A ordinary shares), and BBCQW (Redeemable warrants).
06-08-2026
Bleichroeder Acquisition Corp. II announced that the SEC declared effective its registration statement on Form F-4 for the proposed business combination with Pasqal Holding SAS, a French quantum computing company. The registration statement, originally filed on May 26, 2026, was declared effective on August 5, 2026, and the definitive proxy statement/prospectus has been mailed to Bleichroeder shareholders as of the August 4, 2026 record date. The transaction remains subject to shareholder and regulatory approvals, with risks including potential redemptions that could leave the combined company with insufficient cash.
- · The registration statement on Form F-4 (File No. 333-296239) was originally filed on May 26, 2026 and declared effective by the SEC on August 5, 2026.
- · The definitive proxy statement/prospectus was mailed to Bleichroeder shareholders as of the record date of August 4, 2026.
- · The business combination agreement has been amended three times (Amendment No. 1 on May 26, 2026; Amendment No. 2 on June 25, 2026; Amendment No. 3 on July 22, 2026).
- · The combined company aims to achieve a dual listing on Euronext N.V. Paris following the business combination.
- · Risks include potential shareholder redemptions leaving insufficient cash, failure to obtain required regulatory approvals, and Pasqal's limited operating history in an emerging technology.
06-08-2026
06-08-2026
Samvardhana Motherson International Limited has incorporated an indirect wholly owned subsidiary, Motherson Aerospace Group Holdings Company B.V., in the Netherlands on August 5, 2026. The subsidiary will focus on the aerospace, defence, and security sectors, including development, manufacturing, and trading of related products and systems. The initial subscribed share capital is EUR 100, divided into 10,000 shares of EUR 0.01 each, with no financial consideration or regulatory approvals required for the incorporation.
- · The subsidiary is incorporated under the laws of the Netherlands.
- · The subsidiary is an indirect wholly owned subsidiary via SMAST B.V., which is itself an indirect wholly owned subsidiary of the listed entity.
- · The subsidiary is classified under the Aerospace and Advance Systems industry.
- · No governmental or regulatory approvals were required for the incorporation.
- · The consideration is not applicable as it is a new incorporation, not an acquisition.
06-08-2026
Kajaria Ceramics Limited acquired 44,11,764 Compulsorily Convertible Preference Shares (CCPS) of its wholly-owned subsidiary Kajaria Bathware Private Limited (KBPL) from Aravali Investment Holdings for a cash consideration of Rs. 50 Crore on August 6, 2026. This acquisition fulfills an exit obligation under a 2018 Shareholders' Agreement and makes KBPL entirely owned by Kajaria Ceramics. KBPL reported a turnover of Rs. 413.64 Crore for FY2025-26 but incurred a net loss of Rs. (28.49) Crore, highlighting a mixed financial performance.
- · KBPL was incorporated on May 22, 2013.
- · The acquisition was not a related party transaction.
- · The acquisition consideration of Rs. 50 Crore was lower than Aravali's original investment of Rs. 64.50 Crore in 2018.
- · Post-acquisition, the Shareholders' Agreement (SHA) with Aravali has been terminated.
06-08-2026
H.G. Infra Engineering Limited has acquired 1,30,000 equity shares in its wholly owned subsidiary H.G. Gujarat Bess Private Limited for a cash consideration of Rs. 33.80 crore via a rights issue subscription. The subsidiary, incorporated in February 2025, is focused on battery energy storage systems and had nil turnover as of March 31, 2026. The acquisition is intended for business expansion and was completed on August 6, 2026.
- · The subsidiary H.G. Gujarat Bess Private Limited was incorporated on February 5, 2025, under the Companies Act, 2013, with its registered office in Rajasthan, India.
- · The acquisition is classified as a related party transaction since the subsidiary is a wholly owned entity.
- · The issue price per equity share was Rs. 2,600, including a face value of Rs. 10 per share.
- · No governmental or regulatory approvals were required for the acquisition.
06-08-2026
Majestic Research Services and Solutions Ltd has appointed four new directors pursuant to an order of the National Company Law Tribunal (NCLT) in I.A. (Plan) No. 07/2024 dated 20th June 2025, indicating the company is undergoing a resolution or restructuring process under insolvency proceedings. The appointments include Mrs. Rashmikaben Shaileshbhai Patel as Managing Director, Mr. Parth Patel as Executive Director, Mr. Piyush Jagdishbhai Patel as Non-Executive Independent Director, and Mrs. Avani Vishnubhai Patel as Non-Executive Independent Director, all for five-year terms effective 18th September 2025. No financial figures or performance metrics were disclosed in this filing.
- · Appointments are effective from 18th September 2025.
- · All appointments are for a term of five consecutive years (until 17th September 2030).
- · Appointments are subject to shareholder approval and other regulatory approvals as applicable.
- · Mrs. Rashmikaben Shaileshbhai Patel has over 10 years of experience in ceramic and plastic industries.
- · Mr. Parth Patel holds an MBA in Marketing and has 3 years of professional experience.
- · Mr. Piyush Jagdishbhai Patel is a B.Com graduate and Inter CS with 10 years of experience in corporate laws and business development.
- · Mrs. Avani Vishnubhai Patel has over 12 years of expertise in company secretarial services, 10+ years in trademark law, and 3+ years as a Registered Valuer for Securities & Financial Assets.
- · None of the appointed directors are debarred from holding office by any SEBI order.
06-08-2026
Rajasthan Securities Limited (formerly Rajasthan Gases Limited) has incorporated a wholly owned subsidiary, RSL Securities Private Limited, on August 6, 2026, with a registered office in Nagpur, Maharashtra. The subsidiary will engage in general trading, trading in securities, and allied business activities, with an initial paid-up capital of ₹1,00,00,000 (₹1 Crore). The company has no promoter, promoter group, or group companies as of the filing date.
- · The company has no promoter, promoter group, or group companies as of the filing date.
- · The subsidiary will be a related party of the company upon incorporation.
- · The board meeting approving the subsidiary incorporation was held on July 14, 2026, from 4:00 PM to 5:35 PM.
- · The subsidiary's business is not outside the main line of business of the listed entity.
06-08-2026
Ironwood Institutional Multi-Strategy Fund LLC completed an issuer tender offer to repurchase up to 20% of its outstanding Units, with a transaction valuation of approximately $1.25 billion. The offer expired on March 27, 2026, and the Fund accepted all 119,207.465 Units validly tendered, paying a total net asset value of $163,225,175.02 as of June 30, 2026. Payments were made in July 2026, with a subsequent payment for full tenders expected after October 28, 2026, and early repurchase fees of 5% applied to Units held less than one year.
- · Tender offer was an issuer tender offer subject to Rule 13e-4.
- · Offer expired at 11:59 p.m. EDT on March 27, 2026.
- · All 119,207.465 Units tendered were accepted for repurchase.
- · Cash payments for partial tenders (less than 95% of Units) were wired on or about July 23, 2026.
- · For full tenders (95% or more), an Initial Payment of 95% of NAV was made on or about July 23, 2026, with a Subsequent Payment to follow after October 28, 2026.
- · Early Repurchase Fee of 5% applies to Units held less than one year as of June 30, 2026.
- · The Fund looks through feeder funds to determine full vs. partial tender status.
- · Filing fee was offset by a previous payment made on February 26, 2026.
06-08-2026
Ironwood Multi-Strategy Fund LLC filed a final amendment to its tender offer, reporting that 59,371.487 Units were validly tendered and accepted for repurchase, with a net asset value of $79,818,541.14 as of June 30, 2026. The offer, which expired on March 27, 2026, was part of a larger Master Fund Offer for up to 20% of outstanding units. Payments were made on or about July 23, 2026, with early repurchase fees of 5% applied to units held less than one year, and a subsequent payment for members tendering 95% or more of their units is expected after October 28, 2026.
- · Tender offer expired on March 27, 2026 at 11:59 p.m. Eastern Daylight Time.
- · All 59,371.487 Units tendered were accepted for repurchase.
- · Members tendering less than 95% of their Units received 100% of unaudited NAV less any Early Repurchase Fee.
- · Members tendering 95% or more received an Initial Payment of 95% of unaudited NAV less any Early Repurchase Fee on July 23, 2026, with a Subsequent Payment for the excess after October 28, 2026.
- · Early Repurchase Fee of 5% applies to Units held less than one year as of June 30, 2026.
- · Filing fee was $0 pursuant to SEC No-Action Letter dated April 20, 2017.
06-08-2026
Sun Granite Export Ltd. has been admitted into Corporate Insolvency Resolution Process (CIRP) by the NCLT Cuttack Bench on August 05, 2026, following a Section 7 petition filed by financial creditor Minaxi Suppliers Private Limited. The admitted default amount is ₹3,95,96,011 (including interest), and an Interim Resolution Professional has been appointed. The company disputes the default and claims solvency, citing temporary liquidity issues due to market conditions, but the NCLT has initiated CIRP, triggering a moratorium.
- · CIRP commenced on August 05, 2026, with moratorium effective from that date until completion of CIRP, approval of resolution plan, or liquidation order.
- · Loan Agreement dated 30.04.2024, with interest rate of 9% per annum; principal disbursed in tranches between 15.10.2024 and 18.01.2025.
- · Loan account classified as Non-Performing Asset (NPA) on 30.11.2025.
- · Respondent disputes default, claims solvency, and alleges procedural defects including lack of NeSL Record of Default; also mentions a settlement proposal dated 11.04.2026.
- · Company Petition (IB) No. 14/CB/2026 filed on 06.02.2026.
06-08-2026
The Hon'ble National Company Law Tribunal (NCLT), Cuttack Bench, has admitted a petition under Section 7 of the Insolvency and Bankruptcy Code, 2016, filed by Minaxi Suppliers Private Limited (Financial Creditor) against Sun Granite Export Limited (Corporate Debtor), initiating Corporate Insolvency Resolution Process (CIRP). The default amount is Rs. 3,95,96,011/-, comprising Rs. 3,55,00,000/- principal and Rs. 40,96,011/- unpaid interest. The company has been placed under moratorium, and an Interim Resolution Professional (IRP), Mr. Raghunath Bhandari, has been appointed.
- · The NCLT order was passed on August 05, 2026, and the company was informed on August 06, 2026.
- · The loan was classified as a Non-Performing Asset (NPA) on 30.11.2025 in the financial creditor's books.
- · The corporate debtor disputed the default, claiming solvency and temporary liquidity issues due to market conditions, and alleged procedural defects in the petition.
- · The moratorium commenced on August 05, 2026, and will remain in force until CIRP completion, approval of a resolution plan, or liquidation order.
- · The IRP's registration number is IBBUIPA-002/IP-N01023/2020-2021/113276, with AFA valid until 31.12.2026.
06-08-2026
The Promoter Group of Glen Industries Limited acquired 13,200 equity shares on August 5, 2026 at ₹109.37 per share (aggregate ₹14,43,744) and 31,200 equity shares on August 6, 2026 at ₹112.91 per share (aggregate ₹35,22,840) from public shareholders. As a result, promoter and promoter group shareholding increased from 73.71% to 73.89% of the paid-up equity share capital. The filing is a routine disclosure under Regulation 30 and involves no financial performance metrics.
- · Acquisition price per share: ₹109.37 on Aug 5, and ₹112.91 on Aug 6, 2026.
- · The company states compliance with minimum public shareholding requirements under SEBI ICDR Regulations, 2018.
- · ISIN: INE0UMC01019, Series EQ.
- · Total increase in promoter shareholding: 0.18 percentage points (from 73.71% to 73.89%).
06-08-2026
Mr. Karronn Naresh Bajaj has launched a mandatory open offer to acquire up to 22,88,000 equity shares (26% of voting capital) of Mitshi India Limited at ₹15 per share, for a total consideration of ₹3,43,20,000. The offer opens on September 16, 2026 and closes on September 29, 2026, with no minimum acceptance condition and no competing offer as of the draft letter date. The offer is not conditional on any minimum acceptance level, but acceptance may be proportionate if oversubscribed.
- · Offer is mandatory under SEBI (SAST) Regulations, Regulation 4.
- · No minimum acceptance level required; offer is not conditional on any minimum threshold.
- · No competing offer exists as of the draft letter date.
- · Identified Date for determining shareholders to receive Letter of Offer is September 1, 2026.
- · Offer Price may be revised upward until September 15, 2026.
- · If oversubscribed, acceptance will be on a proportionate basis.
- · Offer may be withdrawn only under specific circumstances (e.g., death of Acquirer, failure of statutory approvals, rescission of Share Purchase Agreement).
- · No statutory approvals required as of the draft letter date, but if any become applicable, the Offer will be subject to them.
06-08-2026
HealthCare Global Enterprises Limited (HCG) announced a further investment of up to INR 16 Crore in its wholly owned subsidiary, HCG Rajkot Hospitals LLP, approved by the Board on August 6, 2026. The funds will be used for repayment of dues, working capital, and general corporate purposes. HCG Rajkot, which operates a 147-bed cancer-specialty hospital in Rajkot, Gujarat, reported revenue of INR 60.67 Crore for FY26, showing a 9.3% increase from INR 55.49 Crore in FY25, though growth slowed from the prior year's near-flat performance.
- · The investment will be completed on or before September 30, 2026.
- · HCG Rajkot was incorporated on September 22, 2017.
- · The transaction is a related party transaction executed at arm's length.
- · No promoter/promoter group interest in the acquisition beyond the subsidiary relationship.
- · No governmental or regulatory approvals are required for the investment.
06-08-2026
Jetking Infotrain Ltd. reported a standalone net loss of Rs. 133.55 Lakh for Q1 FY27, a sharp reversal from a profit of Rs. 39.56 Lakh in the same quarter last year, as total income fell 14.6% YoY to Rs. 603.32 Lakh and expenses rose 10.5% YoY to Rs. 736.87 Lakh. The Board also approved the incorporation of a wholly-owned subsidiary in Singapore for education and training, reappointed M/s PYS & Co LLP as statutory auditor, and accepted the resignation of Company Secretary Supriya Sudheer Kaduskar, appointing Anita Jaiswal as her replacement. Additionally, the company disclosed that its appeal against BSE's rejection of a preferential allotment listing was dismissed by SAT, though management states the order has no material financial impact.
- · The Board approved a revision in the initial investment limit for the company's wholly-owned subsidiary in UAE, attributed solely to foreign exchange rate fluctuations with no change in the underlying proposal.
- · M/s PYS & Co LLP was reappointed as statutory auditor for a second term of 5 consecutive financial years, subject to shareholder approval at the 42nd AGM.
- · The 42nd Annual General Meeting is scheduled for September 29, 2026, to be held via video conferencing.
- · The company has an outstanding arbitration matter regarding an unauthorized trade of Rs. 36.77 Lakh, with an appeal pending admission at the Hon'ble High Court; management believes no provision is required.
- · SAT dismissed the company's appeal against BSE's rejection of listing for 3,96,156 preferential shares; the company is evaluating implications but states no material financial impact for the quarter.
06-08-2026
Elpro International Ltd has acquired 1,03,745 equity shares of GMM Pfaudler Limited for INR 10.00 Crore in cash, marking a fresh acquisition with no prior holding. GMM Pfaudler is an industrial products company with consolidated revenue of ₹3,523.94 Crore for FY 2025-26, up from ₹3,198.69 Crore in FY 2024-25, though down from ₹3,446.48 Crore in FY 2023-24. The acquisition is for investment purposes and is not a related party transaction.
- · GMM Pfaudler was incorporated on 17/11/1962 and operates in the Industrial Products industry.
- · The acquisition is a fresh acquisition; Elpro previously held no shares in GMM Pfaudler.
- · The acquisition is not a related party transaction and no governmental or regulatory approvals are required.
- · The acquisition is for investment purposes and the consideration is cash.
- · GMM Pfaudler's total consolidated revenue declined from ₹3,446.50 Crore in FY 2023-24 to ₹3,229.10 Crore in FY 2024-25, before rising to ₹3,569.01 Crore in FY 2025-26.
06-08-2026
Brookfield Infrastructure Income Fund Inc. filed a final amendment to its tender offer, reporting that it accepted for purchase 100% of the 2,112,774.36 shares validly tendered, representing up to 5.0% of outstanding shares (with an option to purchase an additional 2%). The aggregate net asset value of tendered shares was approximately $23,489,360.09, and the Fund paid approximately $23,451,066.35 (net of early withdrawal fees) on July 31, 2026. The offer expired on June 25, 2026.
- · The Fund reserved the right to purchase up to an additional 2% of outstanding shares under Rule 13e-4(f).
- · The offer expired at 5:00 p.m., Eastern Time, on June 25, 2026.
- · Payment to shareholders was made on or about July 31, 2026.
- · The purchase price was equal to the net asset value per share as of June 30, 2026.
06-08-2026
Privacore PCAAM Alternative Growth Fund filed a final amendment to its tender offer statement, reporting that no shares were tendered by the February 27, 2026 deadline. Consequently, the Fund repurchased $0 of the $3,274,786 originally offered. The tender offer expired with zero participation.
- · The tender offer was first published on January 29, 2026.
- · The deadline for tendering shares was 11:59 p.m. Eastern Time on February 27, 2026.
- · No shares were tendered prior to the expiration of the offer.
- · The net asset value of shares tendered was calculated as of March 31, 2026.
06-08-2026
AB Private Lending Fund filed a final amendment to its tender offer statement, reporting that no shares were tendered by shareholders in the offer that expired on July 30, 2026. As a result, the Fund accepted no shares for purchase. The offer had sought to buy up to 338,368 shares of its Class I, Class D, and Class S shares at net asset value as of June 30, 2026.
- · The tender offer expired at 11:59 p.m., Eastern Time, on July 30, 2026.
- · The purchase price was set at net asset value per share as of June 30, 2026.
- · The original tender offer statement was filed on June 26, 2026.
06-08-2026
Brady Corp filed an 8-K on August 6, 2026, reporting the completion of an acquisition (Item 2.01) and entry into a material definitive agreement (Item 1.01), along with related obligations (Item 2.03) and Regulation FD disclosure (Item 7.01). However, the filing does not disclose the target company, deal value, or financial terms, limiting the ability to assess materiality or strategic impact.
- · The filing includes Item 7.01 (Regulation FD Disclosure), suggesting a concurrent press release or investor presentation was issued.
- · Item 9.01 indicates financial statements and exhibits are attached, but no details are provided in the summary.
- · No target company name, deal value, or financial impact is disclosed in the filing summary.
06-08-2026
Hero MotoCorp's Board of Directors met on August 6, 2026, and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board also approved the setting up of a wholly-owned Section 8 company, 'Hero MotoCorp Foundation - A Santosh Munjal Legacy', to undertake Corporate Social Responsibility initiatives, with an initial infusion of ₹1 crore. The financial results and press release are enclosed but not detailed in this filing, so no performance metrics are available for analysis.
- · The Board meeting commenced at 03:00 p.m. and concluded at 07:45 p.m. on August 6, 2026.
- · The proposed Section 8 company will be a wholly-owned subsidiary of Hero MotoCorp Limited.
- · Incorporation of the Section 8 company requires approval from the Central Government / Ministry of Corporate Affairs.
- · The consideration for the subsidiary is cash, with an initial subscription of ₹1 crore.
06-08-2026
NYSE Arca filed a Form 25-NSE with the SEC on August 6, 2026, to delist the Rayliant SMDAM Japan Equity ETF, a series of Advisors' Inner Circle Fund III. The delisting is effective August 17, 2026, because the fund's securities were converted into the right to receive an immediate cash payment, and trading was suspended on July 31, 2026.
- · The delisting is pursuant to 17 CFR 240.12d2-2(a)(3) because the fund's securities were replaced by the right to receive an immediate cash payment.
- · Trading of the security was suspended on July 31, 2026.
- · The delisting becomes effective at the opening of business on August 17, 2026.
06-08-2026
GCM Grosvenor Core Absolute Return Fund I, LLC filed a final amendment to its Schedule TO, reporting the results of its tender offer to repurchase up to $15,200,000 of its shares. The offer expired on April 27, 2026, with $4,348,918.83 in shares validly tendered and accepted for purchase, representing a take-up rate of approximately 28.6% of the maximum offer amount.
- · The tender offer expired at 12:00 midnight Eastern Time on April 27, 2026.
- · The Valuation Date for the Shares tendered was June 30, 2026.
- · All validly tendered shares ($4,348,918.83) were accepted for purchase and paid by the Fund.
- · The filing is a final amendment reporting the results of the tender offer.
06-08-2026
Hedge Fund Guided Portfolio Solution filed a final amendment to its Schedule TO reporting the results of its issuer tender offer. The offer expired on April 27, 2026, and the fund accepted and paid for $1,641,948.21 of shares tendered, which was significantly below the maximum repurchase amount of $32,600,000. The tender offer was substantially undersubscribed, with only about 5% of the targeted amount tendered.
- · The tender offer expired at 12:00 midnight, Eastern Time, on April 27, 2026.
- · The Valuation Date for the tendered interests was June 30, 2026.
- · All tendered shares were accepted for purchase and paid, subject to holdbacks.
- · The filing is a final amendment reporting the results of the offer.
06-08-2026
GCM Grosvenor Core Absolute Return Master Fund, LLC filed a final amendment to its Schedule TO on August 6, 2026, reporting the results of its issuer tender offer to repurchase up to $32.2 million of its limited liability company interests. The offer expired on April 27, 2026, with only $5.35 million in interests validly tendered and accepted, representing a take-up rate of approximately 16.6% of the maximum offer amount. The low participation rate indicates limited investor interest in tendering shares at the offered terms.
- · The tender offer expired at 12:00 midnight, Eastern Time, on April 27, 2026.
- · The Valuation Date for tendered Interests was June 30, 2026.
- · All validly tendered Interests were accepted for purchase and paid, subject to holdbacks.
- · The filing is a final amendment reporting the results of the offer, as indicated by the checked box.
06-08-2026
GCM Grosvenor Core Absolute Return Fund II, LLC filed a final amendment to its tender offer statement, reporting that $745,007.69 in Shares were validly tendered and accepted for purchase, out of a maximum repurchase price of $17,000,000. The offer expired on April 27, 2026, with a valuation date of June 30, 2026. The actual repurchase amount was significantly below the maximum, indicating low investor participation.
- · The tender offer was an issuer tender offer subject to Rule 13e-4.
- · The Fund availed itself of SEC no-action relief for feeder fund fees (Ironwood Multi-Strategy Fund LLC, April 19, 2017).
- · The offer expired at 12:00 midnight, Eastern Time, on April 27, 2026.
- · The Valuation Date was June 30, 2026.
- · All validly tendered Shares were accepted for purchase and paid.
06-08-2026
GMR Airports Limited has entered into an agreement to subscribe up to 49% of the issued and paid-up share capital in TIM Goa Airport Advertising Private Limited (TGAAPL) for an aggregate cash consideration of up to ~INR 16.59 Cr, payable via equity, loan, or convertible instruments in tranches. TGAAPL, incorporated on May 20, 2025, will acquire the advertisement business at Goa Airport at Mopa from its parent, TIMES Innovative Media Limited, through a novation process. The acquired business has shown strong revenue growth over the past three years (INR 14.33 Cr in FY2024, INR 23.70 Cr in FY2025, INR 30.15 Cr in FY2026), but TGAAPL itself has yet to record any revenue, and the deal is subject to regulatory approvals including BCAS security clearance.
- · TGAAPL was incorporated on May 20, 2025 under the Companies Act, 2013
- · The acquisition is not a related party transaction; promoter/promoter group/group companies hold no interest in the transaction
- · The investment is expected to be consummated after novation of the Advertisement Business and receipt of regulatory approval for security clearance from Bureau of Civil Aviation Security (BCAS)
- · The consideration can be paid via equity, loan, and/or any other instrument convertible to equity, in one or more tranches
- · GMR Airports Limited is the airport sector holding company of the GMR Group with investments in various airport entities and airport adjacency businesses such as Duty Free, Cargo, Car Park, Retail
06-08-2026
Stellus Private Credit BDC filed Amendment No. 1 to its tender offer to purchase up to 685,810.313 of its common shares. The amendment updates the record date to August 5, 2026, and revises the total outstanding shares to 13,721,863.258 as of that date. All other terms of the original offer remain unchanged.
- · Amendment No. 1 is a final amendment reporting the results of the tender offer (box checked).
- · The offer is an issuer tender offer subject to Rule 13e-4.
- · The filing satisfies Rule 13e-4(c)(3) requirements.
- · Original tender offer statement was filed on August 3, 2026.
06-08-2026
Apollo Debt Solutions BDC completed its issuer tender offer, accepting 30,224,152 shares (5% of outstanding) at $23.83 per share, totaling $720,200,422 paid via promissory notes. The offer was oversubscribed with 101,541,297 shares tendered, indicating strong shareholder demand. However, the pro-rata acceptance means many tendering shareholders had only a portion of their shares repurchased.
- · The offer expired on June 15, 2026.
- · Payment was made via non-interest bearing, non-transferable promissory notes, with payment made on or about July 31, 2026.
- · The offer was oversubscribed by approximately 3.36 times (101,541,297 tendered vs 30,224,152 accepted).
- · The repurchase price of $23.83 per share was based on net asset value as of June 30, 2026.
06-08-2026
Accuray Incorporated received approval from Nasdaq to transfer its common stock listing from The Nasdaq Global Select Market to The Nasdaq Capital Market, effective August 6, 2026, due to non-compliance with the $1.00 bid price requirement. The company has been granted an additional 180-day period, until February 1, 2027, to regain compliance. The stock continues to trade under the symbol 'ARAY'.
- · The company received Nasdaq approval on August 4, 2026, for the transfer.
- · The transfer to the Nasdaq Capital Market occurred at the opening of business on August 6, 2026.
- · The Nasdaq Capital Market has substantially similar corporate governance requirements as The Nasdaq Global Select Market.
- · The company was granted an additional 180 days to demonstrate compliance with the $1.00 bid price requirement.
06-08-2026
Hydrofarm completed the sale of Aurora Peat Products to Raven Holdings LLC for $16 million, with $5 million in a promissory note, using proceeds to reduce Term Loan debt. The company also launched Project Agility to scale its logistics services platform, though this business currently represents only a small portion of operating results. While the divestiture simplifies operations and reduces debt, the logistics services segment remains nascent and the company faces ongoing risks including collectability of the note and market demand conditions.
- · The logistics services business currently represents only a small portion of Hydrofarm's operating results.
- · Aurora Peat will continue as a supplier to Hydrofarm's grow media business under a supply agreement.
- · Aurora Peat has secured one of the largest premium-quality Sphagnum peat moss reserves in North America.
- · The sale removes the capital spend of owning and operating peat harvesting assets.
- · The company faces risks including collectability of the $5M promissory note and maintaining Nasdaq listing compliance.
06-08-2026
Apollo S3 Private Markets Fund completed its issuer tender offer, repurchasing 22,774.435 shares at $31.20 per share for a total of $710,455.33. The offer expired on June 15, 2026, and payment was made via promissory notes on July 27, 2026. The offer was undersubscribed, as only 22,774.435 shares were tendered out of the 753,127 shares sought.
- · The offer was undersubscribed: only 22,774.435 shares were tendered out of 753,127 shares sought (approximately 3.0% of the maximum).
- · Payment was made via non-interest bearing, non-transferable promissory notes, with payment made on or about July 27, 2026.
- · The offer expired at 11:59 p.m. Eastern Time on June 15, 2026.
06-08-2026
Liberty Global Ltd. completed the acquisition of Vodafone's 50% stake in VodafoneZiggo for €1.0 billion in cash plus 10% of Ziggo Group's equity, giving Liberty Global full ownership of VodafoneZiggo. The deal closed on July 31, 2026, and Liberty Global plans to distribute its entire interest in Ziggo Group to shareholders and list Ziggo Group on Euronext Amsterdam. Vodafone retains a minority equity interest in Ziggo Group and has certain governance rights, including a director appointment if the spin-off is delayed beyond 18 months.
- · The acquisition was completed under a Sale and Purchase Agreement dated February 18, 2026.
- · Following the transaction, Ziggo Group owns 100% of VodafoneZiggo and all equity interests in Telenet.
- · Liberty Global indirectly holds a 50% minus one share economic interest in Wyre Holding BV through Telenet's 66.8% stake.
- · Vodafone has the right to appoint one director to Ziggo Group's supervisory board if the Spin Transaction is not completed within 18 months.
- · Financial statements and pro forma financial information for the acquired business will be filed within 71 days of the 8-K filing date.
06-08-2026
Antares Private Credit Fund filed a tender offer on August 6, 2026, but the filing does not disclose any specific deal terms, valuation, or strategic rationale. No parties, transaction values, share counts, or financial metrics are provided in the available data. The filing appears to be a procedural document with no actionable quantitative information.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →August 07, 2026
US Pre-Market SEC Filings Roundup — August 07, 2026
US Pre-Market SEC Filings Roundup
August 07, 2026
USA Corporate Events Calendar — August 07, 2026
USA Corporate Events Calendar
August 07, 2026
USA Earnings Calls Schedule — August 07, 2026
USA Earnings Calls Schedule
August 07, 2026
US Merger & Acquisition SEC Filings — August 07, 2026
US Merger & Acquisition SEC Filings